#Promacta - Twitter Hashtag

almost 6 years ago

.@katie_thomas: #Shkreli sponsor John Higgins of $LGND profited from high-priced, worthless indication #Remdesivir, while millions suffer + die from #COVID-19. Same play as #Promacta + dying Hep-C patients #ActivistShorts #CorpGov https://t.co/SLRZewiyA7 https://t.co/ndoOceMBUf

The New York Times

@nytimes

almost 6 years ago

The World Health Organization recommended against using the antiviral remdesivir as a treatment for Covid-19, finding in a review of several trials that it did not improve survival rates for patients nor did it help them recover. https://t.co/EGP22nnLCz

46

530

155

14

0

1

2

0

Dividendenperle @Dividendenperle

about 6 years ago

Nr 6 Novartis (Rendite 20e 4.0%) wird im 2. Quartal von Covid-19 ausgebremst – rechnet mit Normalisierung der Gesundheitssysteme und niedriger 2-stelligen Steigerung des operativen Kernergebnisses 2020 https://t.co/clhz0MNoVy #Novartis #Entrasto #Cosentyx #zolgensma #promacta

Dividendenperle's tweet photo. Nr 6 Novartis (Rendite 20e 4.0%) wird im 2. Quartal von Covid-19 ausgebremst – rechnet mit Normalisierung der Gesundheitssysteme und niedriger 2-stelligen Steigerung des operativen Kernergebnisses 2020
https://t.co/clhz0MNoVy #Novartis #Entrasto #Cosentyx #zolgensma #promacta https://t.co/iDrlG2TAQR

0

2

0

Dividendenperle @Dividendenperle

over 6 years ago

Nr 5 Novartis (Rendite 20e 3.7%) erhält starken Rückenwind von COVID-19 – Umsatz steigt auf USD 12.28 Mrd und der Reingewinn auf USD 2.17 Mrd https://t.co/GYOFxtx60V #Novartis #Entresto #Zolgensma #Cosentyx #Promacta #xiidra

Dividendenperle's tweet photo. Nr 5 Novartis (Rendite 20e 3.7%) erhält starken Rückenwind von COVID-19 – Umsatz steigt auf USD 12.28 Mrd und der Reingewinn auf USD 2.17 Mrd
https://t.co/GYOFxtx60V #Novartis #Entresto #Zolgensma #Cosentyx #Promacta #xiidra https://t.co/RO9jcIOdPc

0

2

0

Shilpa thakur @DRG_Epi_TShilpa

almost 8 years ago

It's proven! #Revolade treatment leads to less thrombotic events than second-line therapies. Check out the latest @DRG_epi report estimating highest 71,000 diagnosed prevalent cases of #chronicITP in the United States in 2019. @DRGinsights #Promacta @Novartis

The PMI (Pharmaceutical Managers' Institute) @PharmaMgrsInst

almost 8 years ago

#MarketWatch Real-world data show Novartis drug Revolade® improves outcomes for ITP patients compared to other second-line therapies https://t.co/k5grWCsw8T @Novartis #realworlddata #health #medicine #ThePMI18 #medicalsciences #revolade #traditionalandalternativemedicin

PharmaMgrsInst's tweet photo. #MarketWatch
Real-world data show Novartis drug Revolade® improves outcomes for ITP patients compared to other second-line therapies
https://t.co/k5grWCsw8T
@Novartis #realworlddata
#health #medicine #ThePMI18 #medicalsciences #revolade #traditionalandalternativemedicin https://t.co/ISeB34zTsc

0

1

2

0

André Bernardes, Data Scientist @BrazilSFE

almost 8 years ago

https://t.co/AwBJBOaLJO #COMPARTILHE #DÊLIKE #Novartis - #Top10 #Pharmaceutical #Companies 2018 ✔ Brazil SFE Company® | Bernardes® #Alcon #Cosentyx #Entresto #Gilenya #Gleevec #Glivec #Mekinist #Novartis #Promacta #Revolade #Sandoz #Tafinlar

0

1

0

MDedge Hematology & Oncology @MDedgeHemOnc

almost 8 years ago

#Eltrombopag approved as first-line SAA therapy https://t.co/UrI8avddfG #Promacta #severeaplasticanemia

0

2

1

0

Hematology News @HematologyNews1

over 8 years ago

FDA update: Promacta gets a priority review from the #FDA as a first-line treatment for severe aplastic anemia https://t.co/Rr1z5ZWWlz #SAA #anema #Promacta